About Arteriocyte
Arteriocyte is a company based in Hopkinton (United States) founded in 2007 by Donald Brown. Arteriocyte has raised $15.11 million across 6 funding rounds from investors including HHS, Cleveland Clinic Innovations and DW Management Services. Arteriocyte offers products and services including Magellan, Influx, and InQu. Arteriocyte operates in a competitive market with competitors including Hemotune, Medcura, ExThera Medical, Lindis Blood Care and CytoPherx, among others.
- Headquarter Hopkinton, United States
- Founders Donald Brown
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Arteriocyte
Arteriocyte offers a comprehensive portfolio of products and services, including Magellan, Influx, and InQu.
System for creating platelet-rich plasma and bone marrow therapies.
Allograft products for bone grafting and healing applications.
Biosynthetic bone graft for faster fusion in medical procedures.
Funding Insights of Arteriocyte
Arteriocyte has successfully raised a total of $15.11M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $2.48 million completed in March 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Arteriocyte
Arteriocyte has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Cleveland Clinic Innovations and DW Management Services.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health tech startups are supported through incubation services.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Arteriocyte
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Arteriocyte
Investment portfolio details for Arteriocyte
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Arteriocyte
Detailed financials for Arteriocyte
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Arteriocyte Comparisons
Peer comparison for Arteriocyte
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Arteriocyte
Arteriocyte operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemotune, Medcura, ExThera Medical, Lindis Blood Care and CytoPherx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of a device for blood purification
|
|
| Locked | Locked | Locked |
Developer of the device for controlling bleeding
|
|
| Locked | Locked | Locked |
Medical devices for the rapid treatment of bloodstream infections and pathogen-reduction in blood banking
|
|
| Locked | Locked | Locked |
Innovative solutions for safer blood transfusions are developed.
|
|
| Locked | Locked | Locked |
Cytopheresis systems for inflammatory conditions
|
Detailed competitors of Arteriocyte
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Arteriocyte
Complete news archive for Arteriocyte
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arteriocyte
Arteriocyte was founded in 2007.
Arteriocyte is headquartered in Hopkinton, United States. It is registered at Hopkinton, Massachusetts, United States.
Arteriocyte is a funded company, having raised a total of $15.11M across 6 funding rounds to date.
Arteriocyte Medical Systems, is a medical device company that develops products to accelerate healing in patients. Its lead product, Magellan Autologous Platelet Separator provides surgeons the ability to fractionate peripheral blood, or a mixture of blood and aspirated bone marrow from a patient. It also produces Demineralized Bone Matrix in the form of powder - MAR0Match or in the form of gel - MAR0Fuse. Other products include Magellan PRP to prepare Platelet Rich Plasma, and MAR0Max kit that provides the surgeon tools needed to Aspirate, Concentrate and Deliver a mixture of whole blood and bone marrow.
Arteriocyte's top competitors include Medcura, ExThera Medical and Lindis Blood Care.
Arteriocyte offers Magellan, Influx, and InQu.
Arteriocyte has 3 investors. Key investors include HHS, Cleveland Clinic Innovations, and DW Management Services.